News
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...
From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...
Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...
Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals ...
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results